Hôpital Beaujon

32 currently recruiting clinical trials
Create patient profile for matching
Phase 3 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer Small intestine and appendix cancer #NCT07087054 #2024-519875-24-00
Required histologic types
Ileum cancer
Required histologic sub types
Neuroendocrine tumor
Required number of previous lines of therapy for current stage of disease
None
Hôpital Beaujon (Clichy)
Crinetics Pharmaceuticals Inc.
Phase 3 Liver and bile duct cancer #NCT07221253 #2025-523085-24-00
Required histologic sub types
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Hôpital Beaujon (Clichy)
AstraZeneca
Phase 3 Liver and bile duct cancer #NCT06921785 #2024-518210-81-00
Required histologic sub types
Hepatocellular carcinoma
Required disease stage
Locally Advanced Metastatic
Required liver status
Unhealthy
Required Child-Pugh scores
A
Required BCLC stage (Barcelona Clinic Liver Cancer)
B C
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Hôpital Beaujon (Clichy)
AstraZeneca
Phase 3 Pancreas cancer Stomach and esophageal cancer #NCT06784752 #2024-518325-15-00
Required histologic types
Stomach
Required histologic sub types
Neuroendocrine tumor
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Required SSTR metabolic imaging statuses
SSTR Positive
Hôpital Beaujon (Clichy)
Novartis
Phase 3 Pancreas cancer Stomach and esophageal cancer #NCT05477576 #2023-509334-19-00
Required histologic types
Stomach
Required histologic sub types
Neuroendocrine tumor
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Somatostatin analogs
Required SSTR metabolic imaging statuses
SSTR Positive
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Beaujon (Clichy)
RayzeBio, Inc
Phase 3 Liver and bile duct cancer #NCT06467357 #2023-508057-19-00
Required histologic sub types
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
HER2
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Immunotherapy Targeted therapy Antibody Drug Conjugates (ADC)
Hôpital Beaujon (Clichy)
AstraZeneca
Phase 3 Liver and bile duct cancer #NCT05615818 #2023-508100-38-00
Required histologic sub types
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Beaujon (Clichy)
UNICANCER
Phase 3 Liver and bile duct cancer #NCT06282575 #2023-508219-21-00
Required histologic sub types
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
HER2
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Immunotherapy Targeted therapy
Hôpital Beaujon (Clichy)
Jazz Pharmaceuticals
Phase 3 Liver and bile duct cancer #NCT04803994 #2024-512953-26-00
Required histologic sub types
Hepatocellular carcinoma
Required disease stage
Locally Advanced
Required liver status
Unhealthy
Required Child-Pugh scores
A B
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Hôpital Beaujon (Clichy)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Colon cancer Rectal cancer Anal cancer #NCT04954820
Required histologic sub types
Neuroendocrine tumor
Required number of previous lines of therapy for current stage of disease
1
Required SSTR metabolic imaging statuses
SSTR Positive
Excluded previous treatments at localized stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Beaujon (Clichy)
Institut du Cancer de Montpellier - Val d'Aurelle